1 Market Overview
    1.1 Product Overview and Scope of Neurological Disease Model
    1.2 Global Neurological Disease Model Market Size and Forecast
    1.3 China Neurological Disease Model Market Size and Forecast
    1.4 China Percentage in Global Market
        1.4.1 By Revenue, China Neurological Disease Model Share in Global Market, 2020-2031
        1.4.2 Neurological Disease Model Market Size: China VS Global, 2020-2031
    1.5 Neurological Disease Model Market Dynamics
        1.5.1 Neurological Disease Model Market Drivers
        1.5.2 Neurological Disease Model Market Restraints
        1.5.3 Neurological Disease Model Industry Trends
        1.5.4 Neurological Disease Model Industry Policy
2 Competitive Landscape by Company
    2.1 Global Neurological Disease Model Revenue by Company, 2020-2025
    2.2 Global Neurological Disease Model Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    2.3 Global Neurological Disease Model Concentration Ratio
    2.4 Global Neurological Disease Model Mergers & Acquisitions, Expansion Plans
    2.5 Global Neurological Disease Model Manufacturers Product Type
    2.6 Global Geographic Distribution of Neurological Disease Model Companies
3 China Competitive Situation by Company
    3.1 China Neurological Disease Model Revenue by Company, 2020-2025
    3.2 China Neurological Disease Model Neurological Disease Model Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    3.3 China Neurological Disease Model Market, Revenue Percentage of Local Players VS Foreign Players (2020-2031)
4 Industry Chain Analysis
    4.1 Neurological Disease Model Industry Chain
    4.2 Neurological Disease Model Upstream Analysis
    4.3 Neurological Disease Model Midstream Analysis
    4.4 Neurological Disease Model Downstream Analysis
5 Sights by Type
    5.1 Neurological Disease Model Classification
        5.1.1 Parkinson's Disease Model
        5.1.2 Alzheimer's Disease Model
        5.1.3 Anxiety Model
        5.1.4 Depression Model
        5.1.5 Traumatic Brain/Spinal Cord Injury Model
        5.1.6 Neonatal Hypoxic-Ischemic Encephalopathy Model
        5.1.7 Others
    5.2 by Type, Global Neurological Disease Model Market Size & CAGR, 2020 VS 2024 VS 2031
    5.3 by Type, Global Neurological Disease Model Market Size, 2020-2031
6 Sights by Application
    6.1 Neurological Disease Model Segment by Application
        6.1.1 Clinical Diagnosis
        6.1.2 Scientific Research
        6.1.3 Others
    6.2 by Application, Global Neurological Disease Model Market Size & CAGR, 2020 VS 2024 VS 2031
    6.3 by Application, Global Neurological Disease Model Market Size, 2020-2031
7 Sights by Region
    7.1 By Region, Global Neurological Disease Model Market Size, 2020 VS 2024 VS 2031
    7.2 By Region, Global Neurological Disease Model Market Size, 2020-2031
    7.3 North America
        7.3.1 North America Neurological Disease Model Market Size & Forecasts, 2020-2031
        7.3.2 By Country, North America Neurological Disease Model Market Size Market Share
    7.4 Europe
        7.4.1 Europe Neurological Disease Model Market Size & Forecasts, 2020-2031
        7.4.2 By Country, Europe Neurological Disease Model Market Size Market Share
    7.5 Asia Pacific
        7.5.1 Asia Pacific Neurological Disease Model Market Size & Forecasts, 2020-2031
        7.5.2 By Country/Region, Asia Pacific Neurological Disease Model Market Size Market Share
    7.6 South America
        7.6.1 South America Neurological Disease Model Market Size & Forecasts, 2020-2031
        7.6.2 By Country, South America Neurological Disease Model Market Size Market Share
    7.7 Middle East & Africa
8 Sights by Country Level
    8.1 By Country, Global Neurological Disease Model Market Size & CAGR，2020 VS 2024 VS 2031
    8.2 By Country, Global Neurological Disease Model Market Size, 2020-2031
    8.3 United States
        8.3.1 United States Neurological Disease Model Market Size, 2020-2031
        8.3.2 By Company, United States Neurological Disease Model Revenue Market Share, 2024
        8.3.3 by Type, United States Neurological Disease Model Revenue Market Share, 2024 VS 2031
        8.3.4 by Application, United States Neurological Disease Model Revenue Market Share, 2024 VS 2031
    8.4 Europe
        8.4.1 Europe Neurological Disease Model Market Size, 2020-2031
        8.4.2 By Company, Europe Neurological Disease Model Revenue Market Share, 2024
        8.4.3 by Type, Europe Neurological Disease Model Revenue Market Share, 2024 VS 2031
        8.4.4 by Application, Europe Neurological Disease Model Revenue Market Share, 2024 VS 2031
    8.5 China
        8.5.1 China Neurological Disease Model Market Size, 2020-2031
        8.5.2 By Company, China Neurological Disease Model Revenue Market Share, 2024
        8.5.3 by Type, China Neurological Disease Model Revenue Market Share, 2024 VS 2031
        8.5.4 by Application, China Neurological Disease Model Revenue Market Share, 2024 VS 2031
    8.6 Japan
        8.6.1 Japan Neurological Disease Model Market Size, 2020-2031
        8.6.2 By Company, Japan Neurological Disease Model Revenue Market Share, 2024
        8.6.3 by Type, Japan Neurological Disease Model Revenue Market Share, 2024 VS 2031
        8.6.4 by Application, Japan Neurological Disease Model Revenue Market Share, 2024 VS 2031
    8.7 South Korea
        8.7.1 South Korea Neurological Disease Model Market Size, 2020-2031
        8.7.2 By Company, South Korea Neurological Disease Model Revenue Market Share, 2024
        8.7.3 by Type, South Korea Neurological Disease Model Revenue Market Share, 2024 VS 2031
        8.7.4 by Application, South Korea Neurological Disease Model Revenue Market Share, 2024 VS 2031
    8.8 Southeast Asia
        8.8.1 Southeast Asia Neurological Disease Model Market Size, 2020-2031
        8.8.2 By Company, Southeast Asia Neurological Disease Model Revenue Market Share, 2024
        8.8.3 by Type, Southeast Asia Neurological Disease Model Revenue Market Share, 2024 VS 2031
        8.8.4 by Application, Southeast Asia Neurological Disease Model Revenue Market Share, 2024 VS 2031
    8.9 India
        8.9.1 India Neurological Disease Model Market Size, 2020-2031
        8.9.2 By Company, India Neurological Disease Model Revenue Market Share, 2024
        8.9.3 by Type, India Neurological Disease Model Revenue Market Share, 2024 VS 2031
        8.9.4 by Application, India Neurological Disease Model Revenue Market Share, 2024 VS 2031
    8.10 Middle East & Africa
        8.10.1 Middle East & Africa Neurological Disease Model Market Size, 2020-2031
        8.10.2 By Company, Middle East & Africa Neurological Disease Model Revenue Market Share, 2024
        8.10.3 by Type, Middle East & Africa Neurological Disease Model Revenue Market Share, 2024 VS 2031
        8.10.4 by Application, Middle East & Africa Neurological Disease Model Revenue Market Share, 2024 VS 2031
9 Company Profile
    9.1 Axion BioSystems
        9.1.1 Axion BioSystems Company Information, Head Office, Market Area, and Industry Position
        9.1.2 Axion BioSystems Company Profile and Main Business
        9.1.3 Axion BioSystems Neurological Disease Model Models, Specifications, and Application
        9.1.4 Axion BioSystems Neurological Disease Model Revenue and Gross Margin, 2020-2025
        9.1.5 Axion BioSystems Recent Developments
    9.2 Creative Biolabs
        9.2.1 Creative Biolabs Company Information, Head Office, Market Area, and Industry Position
        9.2.2 Creative Biolabs Company Profile and Main Business
        9.2.3 Creative Biolabs Neurological Disease Model Models, Specifications, and Application
        9.2.4 Creative Biolabs Neurological Disease Model Revenue and Gross Margin, 2020-2025
        9.2.5 Creative Biolabs Recent Developments
    9.3 Taconic Biosciences
        9.3.1 Taconic Biosciences Company Information, Head Office, Market Area, and Industry Position
        9.3.2 Taconic Biosciences Company Profile and Main Business
        9.3.3 Taconic Biosciences Neurological Disease Model Models, Specifications, and Application
        9.3.4 Taconic Biosciences Neurological Disease Model Revenue and Gross Margin, 2020-2025
        9.3.5 Taconic Biosciences Recent Developments
    9.4 Charles River Laboratories
        9.4.1 Charles River Laboratories Company Information, Head Office, Market Area, and Industry Position
        9.4.2 Charles River Laboratories Company Profile and Main Business
        9.4.3 Charles River Laboratories Neurological Disease Model Models, Specifications, and Application
        9.4.4 Charles River Laboratories Neurological Disease Model Revenue and Gross Margin, 2020-2025
        9.4.5 Charles River Laboratories Recent Developments
    9.5 The Jackson Laboratories
        9.5.1 The Jackson Laboratories Company Information, Head Office, Market Area, and Industry Position
        9.5.2 The Jackson Laboratories Company Profile and Main Business
        9.5.3 The Jackson Laboratories Neurological Disease Model Models, Specifications, and Application
        9.5.4 The Jackson Laboratories Neurological Disease Model Revenue and Gross Margin, 2020-2025
        9.5.5 The Jackson Laboratories Recent Developments
    9.6 Ozgene
        9.6.1 Ozgene Company Information, Head Office, Market Area, and Industry Position
        9.6.2 Ozgene Company Profile and Main Business
        9.6.3 Ozgene Neurological Disease Model Models, Specifications, and Application
        9.6.4 Ozgene Neurological Disease Model Revenue and Gross Margin, 2020-2025
        9.6.5 Ozgene Recent Developments
    9.7 Shanghai Model Organisms Center, Inc.
        9.7.1 Shanghai Model Organisms Center, Inc. Company Information, Head Office, Market Area, and Industry Position
        9.7.2 Shanghai Model Organisms Center, Inc. Company Profile and Main Business
        9.7.3 Shanghai Model Organisms Center, Inc. Neurological Disease Model Models, Specifications, and Application
        9.7.4 Shanghai Model Organisms Center, Inc. Neurological Disease Model Revenue and Gross Margin, 2020-2025
        9.7.5 Shanghai Model Organisms Center, Inc. Recent Developments
    9.8 Brin Case Biotechnology Co., Ltd.
        9.8.1 Brin Case Biotechnology Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
        9.8.2 Brin Case Biotechnology Co., Ltd. Company Profile and Main Business
        9.8.3 Brin Case Biotechnology Co., Ltd. Neurological Disease Model Models, Specifications, and Application
        9.8.4 Brin Case Biotechnology Co., Ltd. Neurological Disease Model Revenue and Gross Margin, 2020-2025
        9.8.5 Brin Case Biotechnology Co., Ltd. Recent Developments
    9.9 OBiO Technology ( Shanghai ) Corp.,Ltd.
        9.9.1 OBiO Technology ( Shanghai ) Corp.,Ltd. Company Information, Head Office, Market Area, and Industry Position
        9.9.2 OBiO Technology ( Shanghai ) Corp.,Ltd. Company Profile and Main Business
        9.9.3 OBiO Technology ( Shanghai ) Corp.,Ltd. Neurological Disease Model Models, Specifications, and Application
        9.9.4 OBiO Technology ( Shanghai ) Corp.,Ltd. Neurological Disease Model Revenue and Gross Margin, 2020-2025
        9.9.5 OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Developments
    9.10 BrainVTA (Wuhan) Co., Ltd.
        9.10.1 BrainVTA (Wuhan) Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
        9.10.2 BrainVTA (Wuhan) Co., Ltd. Company Profile and Main Business
        9.10.3 BrainVTA (Wuhan) Co., Ltd. Neurological Disease Model Models, Specifications, and Application
        9.10.4 BrainVTA (Wuhan) Co., Ltd. Neurological Disease Model Revenue and Gross Margin, 2020-2025
        9.10.5 BrainVTA (Wuhan) Co., Ltd. Recent Developments
    9.11 GemPharmatech Co., Ltd.
        9.11.1 GemPharmatech Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
        9.11.2 GemPharmatech Co., Ltd. Company Profile and Main Business
        9.11.3 GemPharmatech Co., Ltd. Neurological Disease Model Models, Specifications, and Application
        9.11.4 GemPharmatech Co., Ltd. Neurological Disease Model Revenue and Gross Margin, 2020-2025
        9.11.5 GemPharmatech Co., Ltd. Recent Developments
    9.12 Jiangsu Ailingfei Biotechnology Co., Ltd.
        9.12.1 Jiangsu Ailingfei Biotechnology Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
        9.12.2 Jiangsu Ailingfei Biotechnology Co., Ltd. Company Profile and Main Business
        9.12.3 Jiangsu Ailingfei Biotechnology Co., Ltd. Neurological Disease Model Models, Specifications, and Application
        9.12.4 Jiangsu Ailingfei Biotechnology Co., Ltd. Neurological Disease Model Revenue and Gross Margin, 2020-2025
        9.12.5 Jiangsu Ailingfei Biotechnology Co., Ltd. Recent Developments
    9.13 Beijing Biocytogen Co., Ltd.
        9.13.1 Beijing Biocytogen Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
        9.13.2 Beijing Biocytogen Co., Ltd. Company Profile and Main Business
        9.13.3 Beijing Biocytogen Co., Ltd. Neurological Disease Model Models, Specifications, and Application
        9.13.4 Beijing Biocytogen Co., Ltd. Neurological Disease Model Revenue and Gross Margin, 2020-2025
        9.13.5 Beijing Biocytogen Co., Ltd. Recent Developments
    9.14 Kunming Biomed International Ltd.
        9.14.1 Kunming Biomed International Ltd. Company Information, Head Office, Market Area, and Industry Position
        9.14.2 Kunming Biomed International Ltd. Company Profile and Main Business
        9.14.3 Kunming Biomed International Ltd. Neurological Disease Model Models, Specifications, and Application
        9.14.4 Kunming Biomed International Ltd. Neurological Disease Model Revenue and Gross Margin, 2020-2025
        9.14.5 Kunming Biomed International Ltd. Recent Developments
    9.15 Beijing Viewsolid Biotechnology Co., Ltd.
        9.15.1 Beijing Viewsolid Biotechnology Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
        9.15.2 Beijing Viewsolid Biotechnology Co., Ltd. Company Profile and Main Business
        9.15.3 Beijing Viewsolid Biotechnology Co., Ltd. Neurological Disease Model Models, Specifications, and Application
        9.15.4 Beijing Viewsolid Biotechnology Co., Ltd. Neurological Disease Model Revenue and Gross Margin, 2020-2025
        9.15.5 Beijing Viewsolid Biotechnology Co., Ltd. Recent Developments
    9.16 Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd.
        9.16.1 Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
        9.16.2 Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Company Profile and Main Business
        9.16.3 Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Neurological Disease Model Models, Specifications, and Application
        9.16.4 Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Neurological Disease Model Revenue and Gross Margin, 2020-2025
        9.16.5 Jiangsu Dingtai Pharmaceutical Research (Group) Co., Ltd. Recent Developments
    9.17 Sichuan Greentech Biotechnology Co., Ltd.
        9.17.1 Sichuan Greentech Biotechnology Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
        9.17.2 Sichuan Greentech Biotechnology Co., Ltd. Company Profile and Main Business
        9.17.3 Sichuan Greentech Biotechnology Co., Ltd. Neurological Disease Model Models, Specifications, and Application
        9.17.4 Sichuan Greentech Biotechnology Co., Ltd. Neurological Disease Model Revenue and Gross Margin, 2020-2025
        9.17.5 Sichuan Greentech Biotechnology Co., Ltd. Recent Developments
    9.18 Pharmalegacy Laboratories (Shanghai) Co., Ltd.
        9.18.1 Pharmalegacy Laboratories (Shanghai) Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
        9.18.2 Pharmalegacy Laboratories (Shanghai) Co., Ltd. Company Profile and Main Business
        9.18.3 Pharmalegacy Laboratories (Shanghai) Co., Ltd. Neurological Disease Model Models, Specifications, and Application
        9.18.4 Pharmalegacy Laboratories (Shanghai) Co., Ltd. Neurological Disease Model Revenue and Gross Margin, 2020-2025
        9.18.5 Pharmalegacy Laboratories (Shanghai) Co., Ltd. Recent Developments
10 Conclusion
11 Appendix
    11.1 Research Methodology
    11.2 Data Source
        11.2.1 Secondary Sources
        11.2.2 Primary Sources
    11.3 Market Estimation Model
    11.4 Disclaimer